Ipilimumab: tested on its own
67 studies: no other medicine in its arm. Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple MyelomaTerminatedNCT04635735Phase 1/2Results postedReport a problem
- Safety and Efficacy Study of Ipilimumab 3 mg/kg Versus Ipilimumab 10 mg/kg in Subjects With Metastatic Castration Resistant Prostate Cancer Who Are Chemotherapy NaiveCompletedNCT02279862Phase 2Results postedReport a problem
- Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)CompletedNCT02221739Phase 1/2Results postedReport a problem
- GEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain MetastasesCompletedNCT02115139Phase 2Results postedReport a problem
- Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic MelanomaCompletedNCT02107755Phase 2Results postedReport a problem
- Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic RadiosurgeryTerminatedNCT02097732Phase 2Results postedReport a problem
- Ipilimumab Administered to Stage IIIC Stage IV Melanoma After Reg. T Cell Depletion With Denileukin DiftitoxTerminatedNCT02009384Phase 2Results postedReport a problem
- Phase 2 Study of Ipilimumab in Japanese Advanced Melanoma PatientsCompletedNCT01990859Phase 2Results postedReport a problem
- Phase II Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Treating Patients With Stage IV MelanomaTerminatedNCT01970527Phase 2Results postedReport a problem
- Ipilimumab and Local Radiation for Selected Solid TumorsTerminatedNCT01769222Phase 1Results postedReport a problem
- Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced MelanomaTerminatedNCT01709162Phase 2Results postedReport a problem
- Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for MelanomaCompletedNCT01703507Phase 1Results postedReport a problem
- Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant MelanomaTerminatedNCT01696045Phase 2Results postedReport a problem
- Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical CancerCompletedNCT01693783Phase 2Results postedReport a problem
- Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum-sensitive Ovarian CancerCompletedNCT01611558Phase 2Results postedReport a problem
- An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line ChemotherapyCompletedNCT01585987Phase 2Results postedReport a problem
- Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg IpilimumabCompletedNCT01515189Phase 3Results postedReport a problem
- Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate CancerCompletedNCT01498978Phase 2Results postedReport a problem
- RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMACompletedNCT01497808Phase 1/2Results postedReport a problem
- Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung CancerTerminatedNCT01471197Phase 2Results postedReport a problem
- Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation TherapyCompletedNCT01449279Phase 2Results postedReport a problem
- Phase 3 Study of Immunotherapy to Treat Advanced Prostate CancerCompletedNCT01057810Phase 3Results postedReport a problem
- Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced MelanomaCompletedNCT00920907Phase 1Results postedReport a problem
- Study of Immunotherapy to Treat Advanced Prostate CancerCompletedNCT00861614Phase 3Results postedReport a problem
- Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III MelanomaCompletedNCT00636168Phase 3Results postedReport a problem
- Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate CancerCompletedNCT00323882Phase 1/2Results postedReport a problem
- A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab StudiesCompletedNCT00162123Phase 2Results postedReport a problem
- A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial SarcomaTerminatedNCT00140855Phase 2Results postedReport a problem
- MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00112580Phase 2Results postedReport a problem
- MDX-010 in Treating Patients With Recurrent or Refractory LymphomaTerminatedNCT00089076Phase 1/2Results postedReport a problem
- Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate CancerTerminatedNCT06388369Phase 1/2Report a problem
- A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed GlioblastomaTerminatedNCT05074992Phase 2Report a problem
- A Phase I Study of CS1002 in Subjects With Advanced Solid TumorsCompletedNCT04338724Phase 1Report a problem
- A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)CompletedNCT03407105Phase 1Report a problem
- Ipilimumab for Head and Neck Cancer PatientsActive, not recruitingNCT02812524Phase 1Report a problem
- Ipilimumab Combined With a Stereotactic Radiosurgery in Melanoma Patients With Brain MetastasesCompletedNCT02662725Phase 2Report a problem
- A Phase 1 Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Subjects With Select Advanced Solid TumorsCompletedNCT02516527Phase 1Report a problem
- Trial of SBRT With Concurrent Ipilimumab in Metastatic MelanomaCompletedNCT02406183Phase 1Report a problem
- Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid TumorsCompletedNCT02239900Phase 1Report a problem
- Trial of Neoadjuvant Ipilimumab Followed by Melphalan Via Isolated Limb Infusion for Patients With Unresectable In-transit Extremity MelanomaCompletedNCT02115243Phase 1Report a problem
- T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate CancerCompletedNCT02113657Early Phase 1Report a problem
- Trial of Ipilimumab After Isolated Limb Perfusion, in Patients With Metastases MelanomaCompletedNCT02094391Phase 2Report a problem
- A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma.Active, not recruitingNCT02068196Phase 4Report a problem
- SRS (Stereotactic Radiosurgery) Plus IpilimumabTerminatedNCT01950195Phase 1Report a problem
- Study of the Drug Ipilimumab for Metastatic Merkel Cell CarcinomaWithdrawnNCT01913691Phase 2Report a problem
- Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid LeukemiaCompletedNCT01757639Phase 1Report a problem
- Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver MetastasesTerminatedNCT01730157Early Phase 1Report a problem
- Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate CancerActive, not recruitingNCT01688492Phase 1/2Report a problem
- Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable MelanomaStatus unknownNCT01565837Phase 2Report a problem
- Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant MelanomaTerminatedNCT01557114Phase 1Report a problem
- Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast CancerCompletedNCT01502592Phase 1Report a problem
- Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant CancerCompletedNCT01445379Phase 1Report a problem
- THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced DiseaseCompletedNCT01355120Phase 2Report a problem
- The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung CancerCompletedNCT01331525Phase 2Report a problem
- Ipilimumab in Patients With Advanced Melanoma and Spontaneous Preexisting Immune Response to NY-ESO-1CompletedNCT01216696Phase 2Report a problem
- Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for MelanomaCompletedNCT00972933Early Phase 1Report a problem
- Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid LeukemiaWithdrawnNCT00732186Phase 1Report a problem
- Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant MelanomaCompletedNCT00729950Phase 1Report a problem
- Study of Neoadjuvant Ipilimumab in Patients With Urothelial Carcinoma Undergoing Surgical ResectionCompletedNCT00362713Phase 1Report a problem
- Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)CompletedNCT00261365Phase 1/2Report a problem
- Vaccine and Antibody Treatment of Prostate CancerCompletedNCT00113984Phase 1Report a problem
- Study of MDX-010 in Stage IV Breast CancerCompletedNCT00083278Phase 2Report a problem
- Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNCT00058279Phase 1/2Report a problem
- Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell CancerCompletedNCT00057889Phase 2Report a problem
- Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic MelanomaCompletedNCT00050102Phase 2Report a problem
- Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine TherapyCompletedNCT00047164Phase 1Report a problem
- Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung CancerTerminatedNCT00039091Phase 1Report a problem